Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia

2021-01-22

Additional Metadata
Persistent URL	doi.org/10.1038/s41375-021-01128-1, hdl.handle.net/1765/134172
Journal	Leukemia
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Goemans, B., Noort, S. (Sanne), Blink, M., Wang, Y.-D. (Yong-Dong), Peters, S.T.C.J. (Susan T. C. J.), Van Wouwe, J. P., Kaspers, G. (Gertjan), de Haas, V., Kollen, W., van der Velden, V., Gruber, T.A. (Tanja A.)& Zwaan, M. (2021). Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia. Leukemia.https://doi.org/10.1038/s41375-021-01128-1

Publication